BRPI1009874B1 - sistema e método de determinação da concentração de analito em amostra de fluido e biossensor - Google Patents
sistema e método de determinação da concentração de analito em amostra de fluido e biossensor Download PDFInfo
- Publication number
- BRPI1009874B1 BRPI1009874B1 BRPI1009874A BRPI1009874A BRPI1009874B1 BR PI1009874 B1 BRPI1009874 B1 BR PI1009874B1 BR PI1009874 A BRPI1009874 A BR PI1009874A BR PI1009874 A BRPI1009874 A BR PI1009874A BR PI1009874 B1 BRPI1009874 B1 BR PI1009874B1
- Authority
- BR
- Brazil
- Prior art keywords
- analyte concentration
- analyte
- fluid sample
- time
- concentration
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 168
- 238000000034 method Methods 0.000 title claims abstract description 74
- 239000012530 fluid Substances 0.000 title claims abstract description 72
- 230000005284 excitation Effects 0.000 claims abstract description 26
- 238000012360 testing method Methods 0.000 claims description 124
- 238000005534 hematocrit Methods 0.000 claims description 54
- 238000011088 calibration curve Methods 0.000 claims description 47
- 238000009792 diffusion process Methods 0.000 claims description 28
- 125000006850 spacer group Chemical group 0.000 claims description 26
- 239000003153 chemical reaction reagent Substances 0.000 claims description 19
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 9
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 9
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 9
- -1 potassium ferricyanide Chemical compound 0.000 claims description 9
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 8
- 229910052707 ruthenium Inorganic materials 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 5
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- 238000004364 calculation method Methods 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 101
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 60
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 59
- 239000008103 glucose Substances 0.000 description 59
- 239000010410 layer Substances 0.000 description 51
- 210000004369 blood Anatomy 0.000 description 47
- 239000008280 blood Substances 0.000 description 47
- 238000005259 measurement Methods 0.000 description 40
- 238000001514 detection method Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 14
- 230000007704 transition Effects 0.000 description 11
- 239000000470 constituent Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 239000000306 component Substances 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 239000012777 electrically insulating material Substances 0.000 description 3
- 238000003487 electrochemical reaction Methods 0.000 description 3
- 238000013213 extrapolation Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 238000004082 amperometric method Methods 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012992 electron transfer agent Substances 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Electrochemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/410,048 US8101062B2 (en) | 2007-07-26 | 2009-03-24 | System and methods for determination of analyte concentration using time resolved amperometry |
| PCT/US2010/023199 WO2010110945A1 (en) | 2009-03-24 | 2010-02-04 | System and methods for determination of analyte concentration using time resolved amperometry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1009874A2 BRPI1009874A2 (pt) | 2016-03-08 |
| BRPI1009874B1 true BRPI1009874B1 (pt) | 2020-01-28 |
Family
ID=42153885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009874A BRPI1009874B1 (pt) | 2009-03-24 | 2010-02-04 | sistema e método de determinação da concentração de analito em amostra de fluido e biossensor |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8101062B2 (enExample) |
| EP (1) | EP2411797B1 (enExample) |
| JP (2) | JP2012521564A (enExample) |
| AU (1) | AU2010229211B2 (enExample) |
| BR (1) | BRPI1009874B1 (enExample) |
| MX (1) | MX2011009756A (enExample) |
| TW (1) | TWI503539B (enExample) |
| WO (1) | WO2010110945A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007523326A (ja) | 2004-02-06 | 2007-08-16 | バイエル・ヘルスケア・エルエルシー | バイオセンサのための内部標準としての酸化され得る化学種、及び使用方法 |
| KR101477815B1 (ko) | 2005-09-30 | 2015-01-02 | 바이엘 헬스케어 엘엘씨 | 게이트형 전압 전류 측정법 |
| JP5604298B2 (ja) * | 2007-07-26 | 2014-10-08 | ニプロ ダイアグナスティックス，インコーポレーテッド | 時間分解電流測定法を用いて被分析物の濃度を測定する方法及びシステム |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| BRPI0820718A2 (pt) | 2007-12-10 | 2015-06-16 | Bayer Healthcare Llc | Amperometria com porta de leitura rápida |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| ES2700861T3 (es) | 2008-07-10 | 2019-02-19 | Ascensia Diabetes Care Holdings Ag | Sistemas y métodos que incluyen ciclos de trabajo amperométricos y voltamétricos |
| US9918635B2 (en) * | 2008-12-23 | 2018-03-20 | Roche Diabetes Care, Inc. | Systems and methods for optimizing insulin dosage |
| EP2382569B1 (en) | 2008-12-23 | 2024-07-03 | Roche Diabetes Care GmbH | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
| US20120011125A1 (en) | 2008-12-23 | 2012-01-12 | Roche Diagnostics Operations, Inc. | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
| ES2886462T3 (es) * | 2009-09-15 | 2021-12-20 | Agamatrix Inc | Sistema y método biosensor electroquímico implantable |
| EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| BR112012023984A2 (pt) | 2010-03-22 | 2016-08-02 | Bayer Healthcare Llc | compensação residual para um biossensor |
| AU2011303639B2 (en) * | 2010-09-13 | 2015-05-14 | Lifescan Scotland Limited | Analyte measurement method and system with hematocrit compensation |
| JP6043793B2 (ja) | 2011-08-16 | 2016-12-14 | インストゥルメンテーション ラボラトリー カンパニー | 試料処理量を増やすための補間センサデータの外挿 |
| US8560251B2 (en) | 2011-08-16 | 2013-10-15 | Instrumentation Laboratory Company | System and method of increasing sample throughput by estimation of a sensor endpoint |
| ES2757909T3 (es) | 2011-09-21 | 2020-04-30 | Ascensia Diabetes Care Holdings Ag | Analisis de compensación que incluye señales segmentadas |
| US8534115B2 (en) * | 2011-10-17 | 2013-09-17 | Schlumberger Technology Corporation | Systems and methods of determining parameter values in a downhole environment |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| WO2014072820A2 (en) * | 2012-11-08 | 2014-05-15 | Thomas William Beck | Chronoamperometric methods and devices for electrochemical quantification of analytes |
| WO2014100423A1 (en) * | 2012-12-21 | 2014-06-26 | Abbott Diabetes Care Inc. | Method for improving measurement accuracy and devices and systems related thereto |
| US9835578B2 (en) | 2013-06-27 | 2017-12-05 | Lifescan Scotland Limited | Temperature compensation for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9435762B2 (en) | 2013-06-27 | 2016-09-06 | Lifescan Scotland Limited | Fill error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9435764B2 (en) | 2013-06-27 | 2016-09-06 | Lifescan Scotland Limited | Transient signal error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| US9828621B2 (en) | 2013-09-10 | 2017-11-28 | Lifescan Scotland Limited | Anomalous signal error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| KR20160138100A (ko) | 2014-03-07 | 2016-12-02 | 어센시아 다이어비티즈 케어 홀딩스 아게 | 바이오센서 캘리브레이션 코딩 시스템 및 방법 |
| US20160091450A1 (en) | 2014-09-25 | 2016-03-31 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value and their temperature compensated values |
| US20160091451A1 (en) | 2014-09-25 | 2016-03-31 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value |
| GB201420982D0 (en) | 2014-11-26 | 2015-01-07 | Inside Biometrics Ltd | Verifying operation of a meter |
| US9423374B2 (en) | 2015-01-26 | 2016-08-23 | Lifescan Scotland Limited | Reference electrode error trap determined from a specified sampling time and a pre-determined sampling time |
| US9904890B2 (en) | 2015-03-13 | 2018-02-27 | Instrumentation Laboratory Company | Detecting a transient error in a body fluid sample |
| WO2016164574A1 (en) * | 2015-04-07 | 2016-10-13 | Polymer Technology Systems, Inc. | Systems and methods for artificial test strip controls |
| TWI609182B (zh) * | 2016-11-04 | 2017-12-21 | 五鼎生物技術股份有限公司 | 葡萄糖量測裝置與設備 |
| WO2018116887A1 (ja) * | 2016-12-20 | 2018-06-28 | 株式会社堀場製作所 | 測定装置、校正方法、及び、測定装置用プログラム |
| US20180217079A1 (en) * | 2017-01-31 | 2018-08-02 | Cilag Gmbh International | Determining an analyte concentration of a physiological fluid having an interferent |
| CN118483297A (zh) * | 2017-06-30 | 2024-08-13 | 雅培糖尿病护理公司 | 用于采用电化学生物传感器进行分析物检测的方法和设备 |
| DE102017121303A1 (de) | 2017-09-14 | 2019-03-14 | Arntz Beteiligungs Gmbh & Co. Kg | Gummiertes Textilmaterial für eine Riemenlage, zugehörige Kautschukmischung und Riemen |
| WO2019089465A1 (en) * | 2017-10-30 | 2019-05-09 | The Regents Of The University Of California | Calibration free in-vivo measurement of analytes using electrochemical sensors |
| US11382541B2 (en) * | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
| CN110208352A (zh) * | 2019-06-24 | 2019-09-06 | 深圳硅基传感科技有限公司 | 葡萄糖传感器的出厂校准方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0672845B2 (ja) | 1986-09-01 | 1994-09-14 | 富士写真フイルム株式会社 | 分析方法 |
| US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| JPH09292387A (ja) | 1996-04-25 | 1997-11-11 | Kdk Corp | 被測定成分量の測定方法及び被測定成分量の測定装置 |
| US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US7276146B2 (en) | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US20060091006A1 (en) | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
| US7232510B2 (en) | 2000-11-30 | 2007-06-19 | Matsushita Electric Industrial Co., Ltd. | Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
| WO2003000127A2 (en) | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
| US7018843B2 (en) | 2001-11-07 | 2006-03-28 | Roche Diagnostics Operations, Inc. | Instrument |
| KR100475634B1 (ko) | 2001-12-24 | 2005-03-15 | 주식회사 아이센스 | 일정 소량의 시료를 빠르게 도입할 수 있는 시료도입부를구비한 바이오 센서 |
| US6863800B2 (en) | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| EP1489961B1 (en) | 2002-03-22 | 2010-09-29 | Animas Technologies LLC | Improving performance of an analyte monitoring device |
| US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
| KR100729307B1 (ko) | 2002-06-17 | 2007-06-15 | 아크레이 인코퍼레이티드 | 글루코스 탈수소효소를 이용한 글루코스 농도 측정방법 및글루코스 센서 |
| EP1557663B1 (en) | 2002-11-01 | 2007-08-01 | ARKRAY, Inc. | Measuring instrument provided with sold component concentrating means |
| ES2709991T3 (es) * | 2003-08-21 | 2019-04-22 | Agamatrix Inc | Método y aparato para el análisis de propiedades electroquímicas |
| JP4469983B2 (ja) * | 2004-04-23 | 2010-06-02 | 独立行政法人産業技術総合研究所 | 多項目同時測定用バイオセンサおよび該多項目同時測定用バイオセンサの使用方法 |
| AU2006279579A1 (en) | 2005-08-16 | 2007-02-22 | Home Diagnostics, Inc. | Method for test strip manufacturing and analysis |
| WO2007032286A1 (ja) | 2005-09-14 | 2007-03-22 | Sumitomo Electric Industries, Ltd. | バイオセンサ測定機、バイオセンサ測定システム及びバイオセンサ測定方法 |
| US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| US20080020452A1 (en) | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US20090007947A1 (en) * | 2006-12-22 | 2009-01-08 | Angela Spangenberg | Portable weather shielding canopy |
| US20090026094A1 (en) * | 2007-05-11 | 2009-01-29 | Home Diagnostics, Inc. | Two-pulse systems and methods for determining analyte concentration |
| TW200912308A (en) * | 2007-05-21 | 2009-03-16 | Delta Electronics Inc | Biosensor and composition thereof |
| US7972866B2 (en) * | 2007-06-18 | 2011-07-05 | Nipro Diagnostics, Inc. | Biosensor and ultrasonic method of making a biosensor |
| JP5604298B2 (ja) | 2007-07-26 | 2014-10-08 | ニプロ ダイアグナスティックス，インコーポレーテッド | 時間分解電流測定法を用いて被分析物の濃度を測定する方法及びシステム |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
-
2009
- 2009-03-24 US US12/410,048 patent/US8101062B2/en active Active
-
2010
- 2010-02-04 JP JP2012502028A patent/JP2012521564A/ja not_active Withdrawn
- 2010-02-04 EP EP10705219.3A patent/EP2411797B1/en active Active
- 2010-02-04 BR BRPI1009874A patent/BRPI1009874B1/pt active IP Right Grant
- 2010-02-04 AU AU2010229211A patent/AU2010229211B2/en active Active
- 2010-02-04 MX MX2011009756A patent/MX2011009756A/es active IP Right Grant
- 2010-02-04 WO PCT/US2010/023199 patent/WO2010110945A1/en not_active Ceased
- 2010-02-10 TW TW099104136A patent/TWI503539B/zh active
-
2011
- 2011-12-20 US US13/331,346 patent/US8574424B2/en active Active
-
2013
- 2013-08-29 JP JP2013177623A patent/JP2013238623A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TWI503539B (zh) | 2015-10-11 |
| AU2010229211B2 (en) | 2014-02-20 |
| US8574424B2 (en) | 2013-11-05 |
| EP2411797B1 (en) | 2014-10-08 |
| US20120234700A1 (en) | 2012-09-20 |
| MX2011009756A (es) | 2011-09-29 |
| US8101062B2 (en) | 2012-01-24 |
| BRPI1009874A2 (pt) | 2016-03-08 |
| AU2010229211A1 (en) | 2011-10-13 |
| JP2012521564A (ja) | 2012-09-13 |
| TW201037299A (en) | 2010-10-16 |
| US20090194432A1 (en) | 2009-08-06 |
| EP2411797A1 (en) | 2012-02-01 |
| JP2013238623A (ja) | 2013-11-28 |
| WO2010110945A1 (en) | 2010-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1009874B1 (pt) | sistema e método de determinação da concentração de analito em amostra de fluido e biossensor | |
| US8088272B2 (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
| US8080153B2 (en) | Analyte determination methods and devices | |
| US8932445B2 (en) | Systems and methods for improved stability of electrochemical sensors | |
| US20090026094A1 (en) | Two-pulse systems and methods for determining analyte concentration | |
| US20120111739A1 (en) | Dual Frequency Impedance Measurement of Hematocrit in Strips |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: NIPRO DIAGNOSTICS, INC. (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: TRIVIDIA HEALTH, INC. (US) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/02/2010, OBSERVADAS AS CONDICOES LEGAIS. |